30 closest matches · ranked by relevance
Type 2 Diabetes Mellitus · Prediabetic State
Primary: Ability of Different Screening Tests Which Can be Performed Opportunistically (During Outpatient Visits -- at Any Time of Day, Regardless of Meal Status) to Predict…
Colorectal Cancer
Primary: Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) — 598; 192 Participants
Covid19
Primary: Participants Enrolled — 36 Participants
Uterine Cervical Neoplasm · Uterine Neoplasms · Genital Neoplasms, Female
Primary: Screening Completion by Outreach Approach and Prior Screening Behavior — 3671; 3960; 1482; 3956 Participants — p=0.05
Prostate Neoplasm
Primary: The Proportion of Men With a Positive MRI Defined by a Score of 3 or Greater — 17.7 Percentage of participants
Colorectal Neoplasms · Digestive System Diseases · Colonic Diseases
Primary: Sensitivity and Specificity of the Exact CRC Screening Test With Comparison to Colonoscopy, Both With Respect to Cancer. — 92.3; 73.8; 93.3; 73.3 percent
Colorectal Cancer Screening
Primary: Number of Participants Up to Date on Colorectal Cancer Screening — 29; 31 Participants — p=<0.05
Colorectal Cancer
Primary: Percentage of Participants Who Undergo Screening Within 6 Months of Outreach — 17; 31 Participants
Hypertension
Primary: Change in Blood Pressure — -1; -2; -2; -2 mmHg
Neisseria Gonorrhoeae Infection · Chlamydia Trachomatis Infection
Primary: Incidence Rate of Ng Plus Ct Detected at Any Site Whilst Individuals Are Screened vs. Not Screened — 0.155; 0.205 Ng or CT cases per study visit
Colorectal Neoplasms
Primary: Colorectal Cancer Screening — 127; 112 participants — p=0.01
Healthy
Primary: PRISM Chagas Specificity — 23; 16223; 3 participants
Colorectal Cancer · Screening
Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants
Cervical Cancer · Human Papillomavirus Infection
Primary: Primary Screening Participation — 144; 340; 381 Participants
Lung Cancer
Primary: Lung Cancer Deaths — 356; 443 Participants — p=0.004
Healthy
Primary: Alinity s HBsAg Assay Specificity — 16985; 6; 2 Participants
HIV Infections
Primary: Percentage of Tested Participants Newly Diagnosed as HIV Infected — 6; 3 percentage of tested that are positive
Fetal Growth Retardation · Fetal; Slow Growth
Primary: Rate of Small for Gestational Age at Birth Identified Antenatally — 28; 46 Participants
Coronary Artery Disease
Primary: Number of Participants With Combination of All Cause Death, Non-fatal Myocardial Infarction (MI), and Hospitalization for Unstable Angina — 34; 28 Participants
Cervical Neoplasia
Primary: Sensitivity and Specificity — 0.86; 0.80 % of participants correctly diagnosed
Latent Tuberculosis Infection
Primary: TST Induration Will be Interpreted Relative to Risk, in Accordance With Published CDC Guidelines. — 2; 37; 20 participants
Colorectal Cancer · Stomach Disease
Primary: Incidence of Stomach Cancer — 49; 59 Participants
Healthy Donors · HIV Positive
Primary: PRISM HIV O Plus Test Data for Specificity — 10; 15589 participants
Colon Cancer
Primary: Assess Colorectal Cancer Screening Completion — 305; 130 Participants
Hepatitis B · Liver Cirrhosis · Carcinoma, Hepatocellular
Primary: Percentage of Patients Appropriately Seeking Care — 5.7; 4.0 percentage of participants — p=0.5
Depression · Stress Disorders, Post-Traumatic · Suicide
Primary: Compare Rate of PTSD Screening During eScreening Implementation and Sustainment vs. Screening as Usual/Pre-implementation — 724; 1408; 893 Participants — p=<.001
Depression · Medication Administered in Error · Cognitive Impairment
Primary: Proportion of Subjects Cognitively Impaired in Emergency Medical Services (EMS) — 17 percentage of subjects
Early Cancer Detection
Primary: Study Data and Samples Were Used for CancerSEEK Assay Development — 712; 3870; 5; 14 Participants
Colorectal Cancer
Primary: Colorectal Cancer Screening Participation, Defined as Completion of a Guaiac or Immunochemical Stool Occult Blood Test, Colonoscopy, Sigmoidoscopy, or Barium Enem…
Depression · Suicidal Ideation
Primary: Personalized Referral — 22; 15; 11; 18 Recommendations — p=0.083